- A novel antibody–drug conjugate anti-CD19(Fab)-LDM in the treatment of B-cell non-Hodgkin lymphoma xenografts with enhanced anticancer activity
Linlin Jiang et al, 2016, Journal of Drug Targeting CrossRef - Challenges and opportunities to develop enediyne natural products as payloads for antibody-drug conjugates
Ajeeth Adhikari et al, 2021, Antibody Therapeutics CrossRef